| Print
SARTORIUS AG VZO O.N. (SRT3)
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocessis housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
Address
Weender Landstrasse 94-108
Goettingen
DEU
37075
Telephone
+49 5513083232
Forecast key dates
| Name | Key Date |
|---|---|
| Sartorius AG Third Quarter Earnings Conference Call for 2026 | 2026-10-16T13:00:00 |
| Sartorius AG Third Quarter Earnings Results for 2026 | 2026-10-16T00:00:00 |
| Sartorius AG Second Quarter Earnings Conference Call for 2026 | 2026-07-22T13:00:00 |
| Sartorius AG Second Quarter Earnings Results for 2026 | 2026-07-22T00:00:00 |
| Sartorius AG First Quarter Earnings Conference Call for 2026 | 2026-04-16T13:00:00 |
| Sartorius AG First Quarter Earnings Results for 2026 | 2026-04-16T00:00:00 |
| Sartorius AG Annual General Meeting for 2025 | 2026-03-27T12:00:00 |
| Sartorius AG Annual Report for 2025 | 2026-02-17T00:00:00 |
| Sartorius AG Fourth Quarter Earnings Conference Call for 2025 | 2026-01-28T13:00:00 |
| Sartorius AG Fourth Quarter Earnings Results for 2025 | 2026-01-28T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Sartorius AG Third Quarter Earnings Conference Call for 2025 | 2025-10-16T13:00:00 |
| Sartorius AG Third Quarter Earnings Result for 2025 | 2025-10-16T00:00:00 |
| Sartorius AG Second Quarter Earnings Conference Call for 2025 | 2025-07-22T13:00:00 |
| Sartorius AG Second Quarter Earnings Result for 2025 | 2025-07-22T00:00:00 |
| Sartorius AG First Quarter Earnings Conference Call for 2025 | 2025-04-16T13:00:00 |
| Sartorius AG First Quarter Earnings Result for 2025 | 2025-04-16T00:00:00 |
| Sartorius AG Annual General Meeting for 2024 | 2025-03-27T12:00:00 |
| Sartorius AG Annual Report for 2024 | 2025-02-17T00:00:00 |
| Sartorius AG Fourth Quarter Earnings Conference Call for 2024 | 2025-01-28T13:00:00 |
| Sartorius AG Fourth Quarter Earnings Results for 2024 | 2025-01-28T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.